Re: 'ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies' by Mikulska et al.

Re: 'ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies' by Mikulska et al.

Accepted version

Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/302928

Repository DOI

https://doi.org/10.17863/CAM.50003

Files

Accepted version (19.24 KB)

Type

Authors

Jayne, David

https://orcid.org/0000-0002-1712-0637

Keywords

Antigens, Surface, Biological Therapy, CD52 Antigen, Communicable Diseases, Consensus, Humans, Lymphocytes

Journal Title

Clin Microbiol Infect

Journal ISSN

1198-743X
1469-0691

Volume Title

25

Publisher

Elsevier

Publisher DOI

https://doi.org/10.1016/j.cmi.2018.12.025

Rights and licensing

Attribution-NonCommercial-NoDerivatives 4.0 International

Except where otherwised noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International

Collections

University of Cambridge Research Outputs (Articles and Conferences)